Physician profile
Maria Sinishtaj
NPI 1811133713
$2,676.21
in general payments reported to CMS, 2019-2025
20 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $618 · 2022: $465 · 2023: $711 · 2024: $551 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $747.05 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $742.76 | 2021-2025 | Belbuca, Xtampza |
| Nevro Corp. | $351.56 | 2023-2024 | Senza |
| Scilex Pharmaceuticals INC. | $173.89 | 2021-2023 | Ztlido |
| Saluda Medical Americas, INC. | $155.54 | 2024 | Evoke |
| Globus Medical, INC. | $149.57 | 2025 | Senza |
| Uswm, LLC | $67.19 | 2021 | |
| Indivior INC. | $65.80 | 2021-2024 | Sublocade |
| Vertex Pharmaceuticals Incorporated | $29.39 | 2025 | |
| Biodelivery Sciences International, INC. | $27.92 | 2021 | |
| Alnylam Pharmaceuticals INC. | $24.67 | 2023 | Givlaari |
| Siemens Medical Solutions USA, INC. | $22.10 | 2024 | Cios Select |
| Si-Bone, INC. | $19.73 | 2024 | |
| Sanofi-Aventis U.S. LLC | $18.38 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.47 | 2023 | Quviviq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $15.66 | 2021 | |
| Pfizer INC. | $13.58 | 2021 | |
| Orexo US, INC. | $11.84 | 2021 | |
| Redhill Biopharma INC. | $11.78 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Sinishtaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.